| PCMA comments to EBSA OTC RFI - December 4 2023.pdf | |
| PCMA comments to Medicaid RFI on MHPAEA - December 4 2023.pdf | |
| PCMA response to MTF RFI - November 13 2023.pdf | |
| PCMA final comments for 504 proposed rule - November 13 2023.pdf | |
| PCMA comment letter on MHPAEA NPRM - October 17 2023.pdf | |
| PCMA comments on Medicare Prescription Payment Plan Guidance - September 20, 2023.pdf | |
| 2024 Propsed PFS PCMA Comments - September 11 2023.pdf | |
| PCMA comments on CMS-10849 negotiation offer ICR - August 24 2023.pdf | |
| PCMA comments on CY2025 proposed EOB model - August 7 2023.pdf | |
| PCMA comments on MDP – August 7, 2023.pdf | |
| PCMA comments re CMS 10847 - ICR 30 day comments - July 31 2023.pdf | |
| PCMA comments on MDRP - July 25 2023.pdf | |
| PCMA comments related to ONC HTI-1 proposed rule - June 20 2023.pdf | |
| PCMA comments on CMS-10849 negotiation offer ICR - June 20 2023.pdf | |
| PCMA comments on CMS-10849 negotiation offer ICR - June 20 2023.pdf | |
| PCMA comments on HIPAA Privacy Rule To Support Reproductive Health Care Privacy - June 16 2023.pdf | |
| PCMA comments on MDP initial guidance - June 12 2023.pdf | |
| PCMA comments on CY 2025 benefit design - June 5 2023.pdf | |
| PCMA comments on CMS-10788 RxDC PRA - May 25 2023.pdf | |
| PCMA comments on CMS-10844 Small Biotech Exception - 30 day - May 24 2023.pdf | |
| PCMA comments on CMS-10847 negotiation elements - May 22 2023.pdf | |
| PCMA comments on IRA IPAY 2026 Guidance - April 14, 2023.pdf | |
| PCMA comments on CMS-10846 MDP agreement - April 10 2023.pdf | |
| PCMA comments on Coverage of Certain Preventive Services - April 3 2023.pdf | |
| PCMA comments on CMS-10844 Small Biotech Exception - March 27 2023.pdf | |
| Advancing Interoperability and Improving Prior Authorization - PCMA Comments - March 13 2023.pdf | |
| PCMA comments on Medicare Part D Inflation Rebate - March 10, 2023.pdf | |
| PCMA comments on CY 2024 Advance Notice - March 6 2023.pdf | |
| PCMA comments on CMS-4201 2024 Part C D rule - February 13 2023.pdf | |
| PCMA comments on Part 2 proposed rule - January 31 2023.pdf | |
| PCMA Comments in response to USPTO RFI - January 31 2023.pdf | |
| PCMA comments on EHB RFI - January 30 2023.pdf | |
| PCMA comment on 2024 NBPP Proposed Rule - January 30 2023.pdf | |
| PCMA comments to MedCAC re CED - January 13, 2023.pdf | |
| PCMA comments on Draft 2024 Letter to Issuers in the FFEs - January 12, 2023.pdf | |
| PCMA comments on CMS Plan Benefit Package (PBP) and Formulary CY 2024 - January 9 2023.pdf | |
| PCMA comments on F6 Retail Pharmacy Standards and Subrogation Standard - January 9 2023.pdf | |
